Skip to main content
                   

Diabetic Peripheral Neuropathy Clinical Trials: Help Find New Treatments

Participate in Diabetic Peripheral Neuropathy Clinical Trials and explore innovative treatments that could alleviate nerve pain caused by diabetes.

Enroll Now

End the Struggle with Diabetic Nerve Pain

Diabetic Peripheral Neuropathic Pain (DPNP) is a nerve pain condition affecting the legs and feet of people with diabetes. Over time, high blood sugar damages the nerves, leading to sensations like burning, tingling, stabbing pain, or even numbness. If you’re struggling with this, Diabetic Peripheral Neuropathy Clinical Trials could be an opportunity to discover effective treatment for Diabetic Peripheral Neuropathic Pain.

Hightower is working towards a future free from diabetic neuropathic pain. Our approach integrates the latest research and innovative diabetic neuropathy clinical trials to unlock better outcomes and better the life of individuals.

*Participation in the DPNP Clinical Trials is completely free of cost and is your choice.

*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.

Study Information

Diabetic Peripheral Neuropathy

Study NameProtocol NumberSponsor
Diabetic Peripheral Neuropathy

LX9211.1-204-DPN

Lexicon

About Diabetic Peripheral Neuropathy Clinical Trials

We are testing a new investigational drug to see if it can reduce pain caused by diabetic neuropathy. It works by blocking a protein that may be linked to nerve pain.

Participants will be randomly assigned to one of the four groups, where you will either receive the study drug (different doses) or an inactive drug. This will be a blind study.

You’ll also use an electronic diary to track your pain and any medications you take for it.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.

What to Expect in Diabetic Peripheral Neuropathy Clinical Trials

In the PROGRESS study, 416 participants will be randomly assigned to receive either investigational drug or a placebo (inactive substance). The study will last approximately 16 weeks, including a two-week screening period and a 14-week treatment period. You will have an equal chance of being in one of the following groups:

  • Group 1: LX9211 10 mg, once daily
  • Group 2: LX9211 20 mg, once daily
  • Group 3: LX9211 20 mg (for 7 days) then 10 mg, once daily
  • Group 4: Placebo, once daily

During the study, you will use an electronic diary (e-diary) to track your pain levels and any medications you take for relief. This helps researchers monitor the effects of the treatment on your symptoms.

Age

18 Years and older (Adult, Older Adult)

Gender

Male & Female 

Condition

Diabetic Peripheral Neuropathic Pain

Current Status

Recruiting

Step Towards a Pain-Free Life: DPNP Clinical Trial

Diabetic peripheral neuropathic pain is a type of nerve pain that affects the feet and legs of people with diabetes. It results from prolonged high blood sugar levels that damage the nerves over time. This nerve damage can cause a range of uncomfortable sensations, including burning, tingling, stabbing, or numbness in the extremities. Common symptoms include:

  • Burning Sensation: A hot or scalding feeling in the feet and legs.
  • Tingling: Often described as a “pins and needles” feeling.
  • Stabbing Pain: Sharp, shooting pain that can be intermittent or constant.
  • Numbness: A lack of feeling or reduced sensitivity in the feet and legs.

Managing this pain is crucial as it can significantly impact daily activities and quality of life. Effective treatment for Diabetic Peripheral Neuropathic Pain is essential to help alleviate these symptoms and improve overall well-being for those affected.

Frequently Asked Questions -

What causes diabetic peripheral neuropathic pain?

High blood sugar levels over time can damage the nerves, leading to diabetic neuropathy. Poor blood circulation, high cholesterol, and smoking may also contribute to nerve damage.

Who is at risk of developing diabetic peripheral neuropathy?

People with type 1 or type 2 diabetes, especially those with poorly controlled blood sugar levels, are at higher risk. Other risk factors include long-term diabetes, obesity, smoking, and high blood pressure.

Can diabetic peripheral neuropathy be cured?

There is no cure for diabetic peripheral neuropathy, but its symptoms can be managed. Managing blood sugar levels and adopting a healthy lifestyle can slow its progression and reduce pain.

Close Menu